You are here

  • Home
  • Archive
  • Volume 20, Issue Suppl 1
  • TCH-052 Validation of an Automated Method For Compounding Monoclonal Antibody Patient Doses: Case Studies of Bevacizumab, Infliximab and Trastuzumab.

Citation Tools

Article menu

Download PDFPDF

Technology (including: robots for production, incompatibilities, drug production and analytics, CRS)
TCH-052 Validation of an Automated Method For Compounding Monoclonal Antibody Patient Doses: Case Studies of Bevacizumab, Infliximab and Trastuzumab.
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Peters B, Capelle M, Arvinte T, et al
TCH-052 Validation of an Automated Method For Compounding Monoclonal Antibody Patient Doses: Case Studies of Bevacizumab, Infliximab and Trastuzumab.
European Journal of Hospital Pharmacy 2013;20:A87.